InvestorsHub Logo
Followers 829
Posts 119663
Boards Moderated 16
Alias Born 09/05/2002

Re: None

Wednesday, 10/20/2021 4:48:15 PM

Wednesday, October 20, 2021 4:48:15 PM

Post# of 867
ACIP endorses PFE’s Prevnar-20 for_adults_65+_or_19+_ with_medical_conditions:

https://www.businesswire.com/news/home/20211020006069/en

ACIP also endorsed MRK’s V114 for the same patient pool—but only if followed by Pneumovax. Requiring only one shot—and having broader serotype coverage—is a clear marketing edge for PFE in what will be a very large market.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News